Human Defensin-5 (1-9)
Human Defensin-5 (1-9) is an orally active antimicrobial peptide. Human Defensin-5 (1-9) can inhibit metabolic disorders induced by Western-style diet (WSD) or Western-style diet with fructose (WSDF). Human Defensin-5 (1-9) enhances intestinal barrier function by upregulating the gene expression of ileal tight junction protein and mucins. Human Defensin-5 (1-9) can be used for the study of obesity and related metabolic diseases.
For research use only. We do not sell to patients.
- Formula: C40H68N16O12S2
- Molecular Weight:1029.20
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male C57BL/6J mice fed a Western-style diet with fructose (WSDF)[1]
-
Dosage:1.2 mg/kg
-
Administration:i.g., once daily, 6 weeks
-
Result:Achieved liver fat reduction rates with statistical significance and hepatic lipid droplet reduction rates.
Showed a significant decrease in mesenteric fat cell area and a trend of reducing fat cell size.
Reduced blood glucose levels at 30 and 60 min post-glucose challenge and decreased glucose AUC.
Upregulated ileal ZO-1, Muc1 gene expression, showed a trend of upregulating Muc2 and reduced Lac/Man ratio.
Induced ileal Defa5, Lyz1, Reg3γand Wnt signaling molecules (Wnt3, Wnt5a, Wnt9a, Tcf1) gene expression.
Chemical Information
-
Molecular Weight 1029.20
-
Formula C40H68N16O12S2
-
Sequence
Ala-Thr-Cys-Tyr-Cys-Arg-Thr-Gly-Arg-NH2
-
Sequence Shortening
ATCYCRTGR-NH2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RT-PCR
Reverse transcription technology uses RNA as a template to synthesize DNA. RT-PCR is simple, specific and sensitive, and can be used to detect gene expression levels and expression differences in cells; detect RNA virus content; clone cDNA sequences of specific genes.
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Carbohydrates and Mucins: Alcian Blue/Alcian Blue-PAS Staining
Alcian Blue (AB) staining is a cationic copper phthalocyanine dye-based histochemical method that binds electrostatically to negatively charged acidic mucopolysaccharides (glycosaminoglycans and sialomucins), enabling visualization of acidic carbohydrate-rich structures such as epithelial mucins, cartilage matrix, and mast cell granules. Periodic Acid-Schiff (PAS) reaction detects neutral mucopolysaccharides and glycoconjugates by oxidizing vicinal diols to aldehydes, which subsequently react with Schiff reagent to produce a magenta signal. The combined Alcian Blue-PAS (AB-PAS) method allows simultaneous differentiation of acidic (blue) and neutral (magenta) mucins in the same tissue section, enabling mucin subtype discrimination in epithelial tissues and pathological lesions.
-
Research Protocol for Metabolic Diseases
AMP-activated protein kinase, AMPK, is a conserved cellular energy sensor that responds to reduced cellular energy status and coordinates metabolism by increasing ATP-generating catabolic pathways while suppressing ATP-consuming anabolic processes. In metabolic disease research, the AMPK pathway is experimentally relevant because it regulates hepatic lipid synthesis, fatty acid oxidation, glucose production, skeletal-muscle glucose disposal, mTORC1-linked biosynthesis, autophagy, mitochondrial homeostasis, and whole-body energy balance. The central pathway logic is that energy stress, metformin, exercise-like stimulation, or direct AMPK activators increase AMPKα Thr172 phosphorylation and downstream substrate phosphorylation, including ACC and RAPTOR. Phosphorylation of ACC suppresses lipogenesis and supports fatty acid oxidation, whereas phosphorylation of RAPTOR suppresses mTORC1 signaling and links cellular energy status to growth and protein synthesis control. The pathway is linked
-
Real Time qPCR (Q-PCR)
Real-time quantitative PCR (qPCR) quantifies an amplifiable nucleic-acid target by monitoring fluorescence during PCR cycling rather than measuring product only after amplification. The increase in fluorescence tracks accumulation of PCR product, and the quantification cycle (Cq; historically also Ct/CP) is related to the initial amount of target: samples containing more starting target generally reach the defined fluorescence threshold in fewer cycles.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)